🔎 Trials Near Me

Akèy › Skleroderm Difize › Texas › Houston

Etid klinik pou Skleroderm Difize nan Houston, TX

5 etid pou Skleroderm Difize ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Ap rekriteFaz 2
  • Prolato Clinical Research Center, Houston
  • Novel Research LLC, Bellaire · 7 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 28, 2026 · NCT06470048

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Ap rekriteFaz 2
  • EncompaSSc site in Houston, TX, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07287670

Platform Clinical Study for Conquering Scleroderma

Ap rekriteFaz 2
  • University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Ap rekriteFaz 1/2
  • Nkarta Investigational Site, Houston
Laj 18 a 75 · Tout sèks · Mizajou Aug 7, 2026 · NCT06733935

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Ap rekriteFaz 2
  • Artiva Investigational Site Bellaire, Bellaire · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06991114

Etid Skleroderm Difize nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.